Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)IASO-782 in Autoimmune Hematological Diseases
Phase 1
Not yet recruiting
- Conditions
- Warm Autoimmune Haemolytic AnaemiaAutoimmune Thrombocytopenia
- Interventions
- Drug: IASO-782 injectionDrug: placebo
- First Posted Date
- 2024-08-01
- Last Posted Date
- 2024-08-01
- Lead Sponsor
- Shanghai IASO Biotechnology Co., Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT06534021
News
No news found